CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TARSTarsus Pharmaceuticals, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $78.61 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$3.45B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-17 · LINK WILLIAM J PHD (Director) · SELL
  • 2026-09-17 · YARNO WENDY L (Director) · OTHER
  • 2026-09-17 · LINK WILLIAM J PHD (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders279
Shares held58,280,650
Value$3.48B
Percent of shares outstanding132.81%
As of quarter end2026-06-30
RECENT NEWS
  • Tarsus Pharmaceuticals: XDEMVY Now Pays The Bills, And The Retina Deals Work Like Options
  • Tarsus to present 11 abstracts at American Academy of Optometry meeting
  • Tarsus Pharmaceuticals, Inc. · 8-K (2.01,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Tarsus Pharmaceuticals, Inc. (TARS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit